Court hearing to allow Luna Innovations to emerge from bankruptcy set for January 12

Luna Innovations Incorporated (NASDAQ: LUNA) announced today that a bankruptcy court hearing has been set for January 12, 2010, to decide whether to confirm Luna’s Plan of Reorganization and allow Luna to emerge from bankruptcy. If the court confirms Luna’s Plan, Luna could emerge from bankruptcy as early as January 12 or 13. Under the Plan, Luna proposes to pay 100% of its due and payable valid claims, and Luna stockholders will retain their shares of Luna’s Common Stock. As previously announced, the Plan also includes the settlement of Luna’s dispute with Hansen Medical, Inc., which is subject to various conditions.

The bankruptcy court decided to combine the hearing on approval of Luna’s Disclosure Statement with the hearing on confirmation of the Plan, for the purpose of accelerating Luna’s reorganization process. Further information on the court process can be found at http://chapter11.epiqsystems.com/ under Luna Innovations.

As previously announced, in September 2009, a NASDAQ Listing Qualifications Panel (the “Panel”) granted Luna’s request for continued listing on The NASDAQ Stock Market subject to the requirement that Luna demonstrate compliance with all applicable requirements for initial listing on The NASDAQ Capital Market by December 31, 2009, among other requirements. Luna has requested that the Panel grant it a further extension through January 13, 2010, so as to afford Luna the opportunity to emerge from bankruptcy and demonstrate compliance with all applicable listing requirements. There can be no assurances, however, that the Panel will grant Luna’s request for additional time to emerge from bankruptcy or that Luna will timely achieve compliance with the applicable listing requirements for The NASDAQ Capital Market.

http://www.lunainnovations.com/

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neural implants face ethical hurdles, study finds